Good job posting your source Churchill. Let’s go over the key part here.
Overall, case-patients were more likely to have had close contact with a person with known COVID-19 than control participants (aOR = 3.2, 95% CI = 2.0–5.0); 64% of close contacts of case-patients and 48% of those of control participants were family members (p = 0.02), whereas school or child care classmates were reported as close contacts for 15% and 27%, respectively (p = 0.04).
So basically if you look at data that requires the largest amount of power to find an effect, you can say schools don’t cause spread.
Meanwhile, your own study shows a significant increase in close contacts for classmates being their known close contact with covid before testing positive. That’s actually great evidence that schools cause spread.
It’s only spreading at the big box stores… according to stories about contract tracing which I assume are easy to write if you work as a journalist and probably very popular because everyone has heard of Target and Walmart.
LONDON — The head of drugmaker AstraZeneca, which is developing a coronavirus vaccine widely expected to be approved by U.K. authorities this week, said Sunday that researchers believe the shot will be effective against a new variant of the virus driving a rapid surge in infections in Britain.
Even though 70% isn’t as good as the Pfizer or Moderna vaccines, it’s still a little higher than the effectiveness of the flu vaccine in a good year. So seems like it could help reduce the transmission rate while the other ones are still capacity constrained. That’s assuming that the facilities used to make the Oxford vaccine couldn’t easily be repurposed to make the other vaccines.
Churchill your linked study shows a statistically significant association between children who have known positive contacts at their school and being covid positive.
That’s according to the paper itself. I’m not contradicting the CDC. Again, you are not capable of interpreting scientific literature.
Oxford’s free (or $3?) Moderna is the one that’s charging twice as much ($60) for the same thing as Pfizer ($30). Oxford good for the new variant thou’
